About
Neurodegenerative Therapeutics
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
194
By Phase
PHASE2: 5PHASE1: 1
By Status
ENROLLING_BY_INVITATION: 2COMPLETED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1AVAILABLE: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06903286Lead Sponsor
Extension Study of Participants From SPG302-ALS-001
PHASE2Enrolling by invitation
16 participants
Started: May 29, 2025 · Completed: Aug 31, 2026
NCT06833281Lead Sponsor
Extension Study of Participants From SPG302-ALZ-101
PHASE2Enrolling by invitation
24 participants
Started: Mar 25, 2025 · Completed: Dec 31, 2026
NCT06442462Lead Sponsor
Study of SPG302 in Adults With Schizophrenia
PHASE2Recruiting
32 participants
Started: Aug 1, 2024 · Completed: Feb 28, 2026
NCT06427668Lead Sponsor
Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)
PHASE2Active, not recruiting
24 participants
Started: Jul 29, 2024 · Completed: Jun 30, 2026
NCT06413537Lead Sponsor
Study of SPG601 in Adult Men With Fragile X Syndrome
PHASE2Completed
10 participants
Started: Jul 5, 2024 · Completed: Dec 31, 2024
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...